Ind-Swift Laboratories Share Price

Small Cap | Pharmaceuticals and health care | NSE: INDSWFTLAB | BSE: 532305

₹87.95 image-0.79 (-0.89 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 89.48

High (₹) 90.30

Low (₹) 85.67

Prev. Close (₹) 88.74

Volume 20,268

VWAP (₹) 86.49

ROCE (%) 26.09

Industry P/E 43.95

TTM P/E 2.16

P/B Ratio 0.56

Market Cap (₹) Cr.517.72

Dividend Yield (%)--

EPS (₹) 71.24

ROE45.19%

Sales Growth (%) 6.10

Profit Growth (%)781.13

Day Range

90.3090.30

L
H

52 Week Range

81.68186.00

L
H

Historical Returns

Returns (6M)

-37.47 %

Returns (1Y)

-15.76 %

Returns (3Y)

31.17 %

Returns (5Y)

406.92 %

Returns (6M)

-37.47 %

Returns (1Y)

-15.76 %

Returns (3Y)

31.17 %

Returns (5Y)

406.92 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (779.51%) TTM EPS Growth
  • Company with Low Debt
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Company with 779.51% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years
  • Growth in Net Profit Margin (QoQ)
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 30.23

MFI 46.45

ATR 6.38

Commodity Channel Index -111.90

ROC125 -40.46

ROC21 -20.86

Williams %R -95.25

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current87.5189.0890.3186.2884.7183.4881.91
Week Ago95.8197.83101.3192.3390.3186.8384.81
Month Ago109.76112.08116.71105.13102.8198.1895.86

EMA & SMA
info_icon

87.95

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 91.27


9 Day 91.34


10 Day 90.95


12 Day 91.69


14 Day 92.56

20 Day 96.95


26 Day 99.63


50 Day 103.80


100 Day 108.13


200 Day 119.99

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
MITHUN SECURITIES PRIVATE LIMITEDbulkSell28 Jul, 2021₹110.443,00,196BSE
MITHUN SECURITIES PRIVATE LIMITEDbulkBuy28 Jul, 2021₹109.573,00,196BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
12 Sept, 2024GAGAN AGGARWALDisposal₹141.4130,000BSE
03 Sept, 2024Essix Biosciences LimitedAcquisition₹121.0080,00,000BSE
03 Apr, 2024ESSIX BIOSCIENCES LIMITEDAcquisition₹101.0094,99,720BSE
03 Apr, 2024IND SWIFT LIMITEDDisposal₹101.0094,99,720BSE
30 Jun, 2023ATUL KUMAR CHAUBEYDisposal₹86.2338,500BSE
19 Jun, 2023RAJESH NAGDisposal₹72.8125,800BSE
07 Jun, 2023SATISH SHARMADisposal₹72.1514,799BSE
05 Jun, 2023Lovekesh MahajanDisposal₹72.0015,000BSE
03 Jun, 2023Lovekesh MahajanDisposal₹71.4121,940BSE
01 Apr, 2023Neha VermaAcquisition₹55.5058,792BSE

Corporate Actions

No corporate actions available.

Announcements

DateSourceDetail
11 Mar, 2025BSE IndiaPlease refer attached pdf.
11 Mar, 2025NSE IndiaInd-Swift Laboratories Limited has informed the Exchange regarding ''INTIMATION OF RECEIPT OF ""BEST EMPLOYER BRAND PUNJAB 2025""AWARD''.
25 Feb, 2025NSE IndiaInd-Swift Laboratories Limited has submitted the Exchange a copy Scrutinizer''s report of NCLT Convened General Meeting of the Unsecured Creditors held on February 22, 2025. Further, the company has informed the Exchange regarding voting results
25 Feb, 2025NSE IndiaInd-Swift Laboratories Limited has submitted the Exchange a copy Srutinizers report of NCLT Convened General Meeting held on February 22, 2025. Further, the company has informed the Exchange regarding voting results.
25 Feb, 2025BSE IndiaVoting Results and Scrutinizer''s Report of the NCLT convened meeting of Unsecured Creditors of the company held on 22/02/2025 are enclosed herewith
25 Feb, 2025BSE IndiaVoting Results and Scrutinizer''s Report of the NCLT convened meeting of the equity shareholders of the company held on 22/02/2025 is enclosed herewith.
22 Feb, 2025NSE IndiaInd-Swift Laboratories Limited has informed the Exchange regarding Proceedings of NCLT Convened Meeting of the Unsecured Creditors held on February 22, 2025
22 Feb, 2025BSE IndiaThe proceedings of the NCLT convened Meeting of the Unsecured Creditors of Ind Swift Laboratories Limited is enclosed herewith.
22 Feb, 2025NSE IndiaInd-Swift Laboratories Limited has informed the Exchange regarding Proceedings of NCLT Convened General Meeting held on February 22, 2025
22 Feb, 2025BSE IndiaThe proceedings of the NCLT Convened Meeting of the Equity Shareholders of Ind Swift Laboratories Limited is enclosed herewith.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results(Revised)13 Feb, 202513 Feb, 2025
Quarterly Results(BM Cancelled)13 Feb, 202512 Feb, 2025
Quarterly Results--07 Nov, 202411 Nov, 2024
Quarterly Results--02 Aug, 202412 Aug, 2024
Preferential issue of shares--26 Jun, 202427 Jun, 2024
Audited Results--07 May, 202413 May, 2024
Quarterly Results--30 Jan, 202412 Feb, 2024
Quarterly Results--31 Oct, 202307 Nov, 2023
Quarterly Results--02 Aug, 202309 Aug, 2023
Audited Results--17 May, 202329 May, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Aug, 2024Jun, 2024Mar, 2024Dec, 2023

About Ind-Swift Laboratories

Ind-Swift Laboratories is a Public Limited Listed company incorporated on 04/01/1995 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24232CH1995PLC015553 and registration number is 015553. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1227.32 Cr. and Equity Capital is Rs. 59.09 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1995

Managing Director

Mr. Navrattan Munjal

NSE Symbol

INDSWFTLAB

Ind-Swift Laboratories Management

NameDesignation
Mr. Navrattan MunjalChairman & Managing Director
Mr. Himanshu JainJoint Managing Director
Mr. Rishav MehtaExecutive Director
Mr. Sahil MunjalExecutive Director
Mr. S P SharmaIndependent Director
Mr. Param Bir SinghIndependent Director
Dr. Ashwani Kumar VigIndependent Director
Mr. Rajinder Kumar GuptaIndependent Director
Ms. Neerja ChathleyIndependent Woman Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on Ind-Swift Laboratories

What is the share price of Ind-Swift Laboratories?

The share price of Ind-Swift Laboratories on 13 Mar, 2025 is ₹ 87.95.

What is 52W high and 52W low share price of Ind-Swift Laboratories?

The highest and lowest 52W share prices of Ind-Swift Laboratories are ₹ 186.000 and ₹ 81.680

What is the market cap of Ind-Swift Laboratories?

The market capitalization of Ind-Swift Laboratories as of 13 Mar, 2025 is ₹ 517.72 Crores

What is the P/E ratio of Ind-Swift Laboratories?

The current P/E ratio of Ind-Swift Laboratories as of 13 Mar, 2025 is 43.95

What is the PB ratio of Ind-Swift Laboratories?

The PB ratio of Ind-Swift Laboratories as of 13 Mar, 2025 is 0.56

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited